ENTITY
Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine (600276 CH)

271
Analysis
Health CareChina
Jiangsu Hengrui Medicine Co., Ltd. develops, manufactures, and markets a variety of medicines and medicine packing materials. The Company's products include anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and other related products.
more
02 Jun 2024 10:05

Northbound Flows (May 31st): Zijin Mining, China Yangtze Power, Montage Technology, Moutai, CMB

We analyzed northbound Shanghai/Shenzhen connect flows in the past week and highlight flows for Zijin Mining, China Yangtze Power, Montage...

Logo
287 Views
Share
01 Jun 2024 22:09

Mainland Connect NORTHBOUND Flows (To 31 May 2024): Net Sell Flows on Weak Gross Volumes

NORTHBOUND Connect sees net selling again to end the month of May. Zijin and Yangtze Power and a host of renewables-related companies on the buy...

Logo
385 Views
Share
27 May 2024 08:30

Shanghai Henlius Biotech (2696.HK) - Behind the Trading Halt and Privatization Rumor

​Rumors swirl around Henlius's trading halt, raising questions about privatization.Henlius faces challenge in the market due to high debt, with...

Logo
360 Views
Share
26 May 2024 17:07

Mainland Connect NORTHBOUND Flows (To 24 May 2024): Weak Net Buy, Weak Gross, Idiosyncratic Flows

Weaker volumes, lower nets. NORTHBOUND now clearly buying CATL and Luxshare and finance and utilities. Selling some tech. The question which arises...

Logo
294 Views
Share
26 May 2024 13:16

What's Still Concerning in the HLB Situation & HLB Life Science's Stock Rights Trading Next Week

This post investigates what's confirmed and still concerning in the HLB situation, and explores the immediate trading opportunity in HLB Life...

Logo
392 Views
Share
x